GERALD KELTY: Open Payments
NPI 1417989823 · SALT LAKE CITY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$737 in 42 payments from 21 companies in 2025. Trend: 2023 $2,176 · 2024 $1,021 · 2025 $737
Food & beverage: $737
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $159 |
| PFIZER INC. | 5 | $73 |
| ViiV Healthcare Company | 3 | $66 |
| GlaxoSmithKline, LLC. | 3 | $50 |
| Gilead Sciences, Inc. | 3 | $49 |
| Astellas Pharma US Inc | 2 | $45 |
| Abbott Laboratories | 2 | $37 |
| Inspire Medical Systems, Inc. | 2 | $33 |
| Verity Pharmaceuticals Inc. | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $21 |
Products named: QULIPTA, UBRELVY, APRETUDE, NURTEC ODT, Veozah, FREESTYLE LIBRE 3, INSPIRE, Tlando.
Industry payments across UT — which companies pay providers there.
